Esperion Therapeutics
Price & Volume
Stats
See moreOpen | $0.99 |
Previous Close | $0.98 |
Day Range | $0.98-$1.10 |
52W Range | $0.81-$3.94 |
Market Cap | $194.9M |
Shares Short | 30M |
Financials
See moreRevenue (12 Mos) | $332.3M |
Revenue Growth (YoY) | 114.3% |
Gross Profit (12 Mos) | $217.4M |
Diluted EPS | -$0.28 |
News
See moreYahoo Finance • 23 days ago
Esperion to Host R&D Day to Highlight Cardiometabolic Pipeline Innovation and Next-Generation Therapeutics on April 24, 2025
Yahoo Finance • 2 months ago
Esperion Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 2 months ago
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
Yahoo Finance • 2 months ago
Esperion to Report Fourth Quarter and Full Year 2024 Financial Results on March 4
About
CEO | Mr. Sheldon L. Koenig |
Address | 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 304 |
